Aquestive Therapeutics, Inc. AQST Q1 2025 earnings
Reported May 12, 2025 · After market close
Revenue estimate$12.2M
EPS estimate-$0.17
Next report
Aug 10, 2026 (In 4 weeks)Revenue estimate$11.4M
EPS estimate-$0.10
Financials
Q1 2025Valuation & ratios
Segments
By segment
Versus estimates
Revenue
Diluted EPS
Ask the moment Aquestive Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Aquestive Therapeutics, Inc. report Q1 2025 earnings?
- Aquestive Therapeutics, Inc. (AQST) reported Q1 2025 earnings on May 12, 2025 after market close.
- What were Aquestive Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Aquestive Therapeutics, Inc. reported revenue of $8.7M and diluted EPS of $-0.24 for Q1 2025.
- Did Aquestive Therapeutics, Inc. beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $12.2M by $3.5M. EPS missed the consensus estimate of $-0.17 by $0.07.
- How did Aquestive Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 27.7% from $12.1M a year earlier and diluted EPS declined 41.2% from $-0.17.
- Where can I find Aquestive Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-024664) directly on SEC EDGAR. The filing index links above go to sec.gov.